EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
EXOZYMES INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$4.00−0.09 (-2.20%)
Close on Oct 19, 2026
- Market cap
- $34.64M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$8.68 (−68.45%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $34.64M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 9.48
- Dividend yield
- –
- Free cash flow yield
- -20.61%
Fundamentals
- Net income
- -$10.19M
- EPS, diluted
- -$1.20
- Free cash flow
- -$7.14M
- Book value per share
- $0.42
- Diluted shares
- 9M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
–
Operating income
-$10.56M
Net income
-$10.19M
EPS, diluted
-$1.20
Free cash flow
-$7.14M
Reported periodTrailing twelve months